The APCaRI Registry and Biorepository, established in 2014, facilitates the collection of clinical and patient-reported data plus biospecimens, to measure prostate cancer outcomes and support the development and clinical translation of innovative technologies. The ultimate goal is to better diagnose and predict outcomes for patients with prostate cancer.

AUTHOR: CATALINA VASQUEZ, MICHAEL KOLINSKY, RUME DJEBAH, MAXWELL UHLICH, BRYAN DONNELLY, ADRIAN S FAIREY, ERIC HYNDMAN, NAWAID USMANI, JACKSON WU, PETER VENNER, DEAN RUETHER, GERALD TODD, MICHAEL CHETNER, R TRAFFORD CRUMP, PERRIN H BEATTY, JOHN D LEWIS

Full Article